濮阳东方男科医院很不错-【濮阳东方医院】,濮阳东方医院,濮阳东方看男科口碑好收费低,濮阳东方妇科医院做人流价格便宜,濮阳东方收费公开,濮阳东方医院治早泄口碑很好放心,濮阳东方医院妇科做人流评价好很不错,濮阳东方男科医院评价好收费低

BEIJING, Sep. 1 (Xinhuanet) -- A campaign is being launched across U.S. to help lovers of sugar drinks reduce their habit by the Center for Science in the Public Interest.This campaign is based on the findings of a new survey conducted by CDC (Centers for Disease Control)."Men drink more than women, and teens and young adults drink the most," said Cynthia L. Ogden who is an epidemiologist at the CDC's National Center for Health Statistics.The campaign is called "Life's Sweeter with Fewer Sugary Drinks." And it aims to decrease intake of soda and sugary drinks down to the American Heart Association recommendation of fewer than three cans per person per week.Sugary drink intake in the U.S. has increased over the last 30 years, which has been linked with weight gain, obesity, poor diet, and type 2 diabetes.So far, the cities signing on include Boston, Chicago and Los Angeles.
BEIJING, Sept. 28 (Xinhuanet) -- The unmanned Shenzhou VIII, part of China's first spacecraft rendezvous and docking mission, will be launched in early November. Niu Hongguang, deputy commander-in-chief of the program, said on Tuesday the launch has not been affected by the postponed lift-off of the Tiangong-1 space module. Tiangong-1 was to enter a low orbit around Earth at the end of August before being met by Shenzhou VIII. However, the departure was pushed back after a satellite failure on Aug 18. Out of safety concerns, Niu said mission commanders ordered a halt to testing at Jiuquan Satellite Launch Center on Tiangong-1 and its carrier rocket, Long March II-F T1. China Aerospace Science and Technology Corp, which designed and made the rocket carrier that failed to launch, formed an expert panel to investigate and made modifications. A successful launch of a communication satellite on Sept 19 using the Long March II-C showed the measures worked, Niu said, adding: "We now have confidence in the launch of Tiangong-1." The module is a "simplified" space lab that will not only be a docking target, but will also work as a space experimental platform. It will be unmanned for most of its two years of use, although astronauts will spend time onboard for short periods. After Shenzhou VIII, the country will launch Shenzhou IX and Shenzhou X next year to rendezvous and dock with Tiangong-1. Niu confirmed Shenzhou X will be manned. Tiangong-1 can accommodate two to three astronauts. "Whether Shenzhou IX will be manned is up to the results of the first rendezvous and docking mission," he said. The rocket carrier with Tiangong-1 atop stands 52 meters tall, with a takeoff weight of 493 tons. Tiangong-1 was scheduled for launch in between Sept 27 and 30, but due to weather forecasts that predicted a cold air mass would move into the area of Jiuquan Satellite Launch Center, it is believed that conditions on Thursday and Friday will be suitable for takeoff.

XICHANG, Sichuan, July 12 (Xinhua) -- China blasted off a new data relay satellite "Tianlian I-02" on Monday at the Xichang Satellite Launch Center in southwest Sichuan Province .The satellite was launched on a Long March-3C carrier rocket at 11:41 p.m. (Beijing Time), said sources with the center.Developed by the China Academy of Space Technology under the China Aerospace Science and Technology Corporation, the satellite is the country's second data relay satellite.China launched its first data relay satellite "Tianlian I-01" on April 25, 2008.The two satellites will form a network to offer data relay and measurement and control service for China's spacecrafts and planned space stations, according to the center.They will also be used to help perform the nation's first space docking, scheduled for the second half of 2011.China plans to launch Tiangong-1 and Shenzhou-8 spacecraft in the latter half of this year, and they will perform the nation's first space docking.Monday's launch is the 140th mission of China's Long March series of rockets.
WASHINGTON, July 27 (Xinhua) -- Astronomers studying observations taken by NASA's Wide-field Infrared Survey Explorer (WISE) mission have discovered the first known "Trojan" asteroid orbiting the sun along with Earth, the U.S. National Aeronautics and Space Administration (NASA) announced Wednesday in a statement.Trojans are asteroids that share an orbit with a planet near stable points in front of or behind the planet. Because they constantly lead or follow in the same orbit as the planet, they never can collide with it. In our solar system, Trojans also share orbits with Neptune, Mars and Jupiter. Two of Saturn's moons share orbits with Trojans.Scientists had predicted Earth should have Trojans, but they have been difficult to find because they are relatively small and appear near the sun from Earth's point of view."These asteroids dwell mostly in the daylight, making them very hard to see," said Martin Connors of Athabasca University in Canada, lead author of a new paper on the discovery to be published Thursday in the journal Nature. "But we finally found one, because the object has an unusual orbit that takes it farther away from the sun than what is typical for Trojans. WISE was a game-changer, giving us a point of view difficult to have at Earth 's surface."The WISE telescope scanned the entire sky in infrared light from January 2010 to February 2011. Connors and his team began their search for an Earth Trojan using data from NEOWISE, an addition to the WISE mission that focused in part on near-Earth objects, or NEOs, such as asteroids and comets. NEOs are bodies that pass within 28 million miles (45 million kilometers) of Earth 's path around the sun. The NEOWISE project observed more than 155, 000 asteroids in the main belt between Mars and Jupiter, and more than 500 NEOs, discovering 132 that were previously unknown.The team's hunt resulted in two Trojan candidates. One called 2010 TK7 was confirmed as an Earth Trojan after follow-up observations with the Canada-France-Hawaii Telescope on Mauna Kea in Hawaii.The asteroid is roughly 1,000 feet (300 meters) in diameter. It has an unusual orbit that traces a complex motion near a stable point in the plane of Earth's orbit, although the asteroid also moves above and below the plane. The object is about 50 million miles (80 million kilometers) from Earth. The asteroid's orbit is well-defined and for at least the next 100 years, it will not come closer to Earth than 15 million miles (24 million kilometers).
HONG KONG, July 19 (Xinhua) -- A gene controlled by male hormone was critical for the growth of liver tumor, leading to a higher incidence of the disease in men than in women, according to the Chinese University of Hong Kong which made the results public on Tuesday.There is a significant gender bias in liver cancer incidence. In Hong Kong, men are three times more likely to develop liver cancer than women. Such phenomenon prompted researchers from the university to carry out a genomic location analysis in liver cancer cells starting from 2008.The researchers discovered, out of 17,000 human genes, that a gene called Cell Cycle-Related Kinase (CCRK) was directly controlled by androgen receptor. They further found that CCRK was critical for the induction of signaling pathway leading to abnormal liver cell growth and tumor formation.The results also reveal that 70 percent of patients with liver cancer were found to produce high levels of CCRK. More importantly, these patients were more likely to have late-stage cancers and lived shorter than those with low CCRK level.Using mouse models, the researchers found that either lowering the level or blocking the signaling pathway of CCRK in liver cancer cells could significantly reduce the tumor growth rate.The study has validated that CCRK is an important gene that has potential to cause liver cancer and the gene can be tested as a new targeted therapy in future.Vice-Chancellor of the university Joseph Sung, who is also team leader of the research project, said the results explained why men have a higher risk of liver cancer than women and helped push ahead with the development of a novel treatment of the disease.The above study results were published online in July in Journal of Clinical Investigation.
来源:资阳报